Chuong Le v. State of Arkansas

2025 Ark. App. 165, 709 S.W.3d 833
CourtCourt of Appeals of Arkansas
DecidedMarch 12, 2025
StatusPublished

This text of 2025 Ark. App. 165 (Chuong Le v. State of Arkansas) is published on Counsel Stack Legal Research, covering Court of Appeals of Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Chuong Le v. State of Arkansas, 2025 Ark. App. 165, 709 S.W.3d 833 (Ark. Ct. App. 2025).

Opinion

Cite as 2025 Ark. App. 165 ARKANSAS COURT OF APPEALS DIVISION II No. CV-23-716

Opinion Delivered March 12, 2025 CHUONG LE APPELLANT APPEAL FROM THE WASHINGTON COUNTY CIRCUIT COURT [NO. 72PR-23-596] V. HONORABLE BETH STOREY BRYAN, STATE OF ARKANSAS JUDGE APPELLEE AFFIRMED

WENDY SCHOLTENS WOOD, Judge

Chuong Le appeals a forty-five-day commitment order entered by the Washington

County Circuit Court. He contends that the court’s order is invalid because he was given

long-acting medication before the relevant statutes allowed it to be administered; the order

does not incorporate a treatment plan by reference, as required; and the exhibits admitted

do not comport with the statutory definition of a treatment plan. Le also claims that the

circuit court lacked jurisdiction to enter the order. We affirm.

On April 18, 2023, Le was admitted to the mental-health unit at Northwest Medical

Center in Springdale (NWMC). Dr. Shankar Yalamanchili treated Le during that stay and

diagnosed him with schizoaffective disorder, bipolar type, with symptoms of schizophrenia

and mania. Upon discharge on June 12, Le was administered Invega Sustenna, a long-lasting

drug used to treat, among other things, schizoaffective disorder. On July 3, Le’s family brought him back to NWMC because he was attacking himself

and his parents, was breaking things, and believed that people from church were trying to

“kill and eat him.” On July 5, Joanne Charles, the social worker who worked with Le during

his prior admission at NWMC, filed a petition in the Washington County Circuit Court to

involuntarily commit Le for evaluation and treatment pursuant to Arkansas Code Annotated

sections 20-47-207 and -210 (Repl. 2018). When a person is a danger to himself or others

and immediate confinement appears necessary, the person may be temporarily detained and

confined, but a hearing must be held within seventy-two hours of detention. Ark. Code Ann.

§§ 20-47-207, -210. Charles alleged in the petition that Le was not oriented to time, place,

or situation; responded to internal stimuli; stood in the shower with his clothes on; played

in the toilet water; refused his medications, including insulin; was experiencing auditory and

visual hallucinations and paranoia; and was spontaneously yelling, destroying property, and

hitting himself. On July 5, the circuit court entered an order for immediate detention and

evaluation and set a hearing pursuant to Arkansas Code Annotated section 20-47-209 (Repl.

2018)—known as a probable-cause or Section Five hearing—for the next day.

At the Section Five hearing, Dr. Yalamanchili testified that he was familiar with Le

from his past admissions; that he had attempted to conduct a clinical interview with Le on

the day of the hearing, but Le had refused to participate; and that he had previously

diagnosed Le with schizoaffective disorder, bipolar type. He opined that Le was not able to

manage himself in his current state and lacked the capacity to care for himself if discharged.

He said that Le had been prescribed Invega Sustenna during his previous hospital stay, had

2 been administered a dose before discharge on June 12, and had filled the prescription for

Invega on June 16. He said the first dose is typically given at the hospital, a second dose is

usually administered “on the outside” a week later, and then a maintenance dose is injected

every thirty days thereafter.

The circuit court entered a probable-cause order on July 6 involuntarily committing

Le to the Arkansas State Hospital System for a period of seven days for evaluation to

determine whether treatment for mental illness was appropriate and setting a hearing on July

14 pursuant to Arkansas Code Annotated section 20-47-214 (Repl. 2018)—known as a

Section Nine hearing. A Section Nine hearing must be held within seven days of detention

(excluding weekends or holidays) to determine whether detention for up to forty-five days

for treatment is necessary. Ark. Code Ann. §§ 20-47-205(b)(1), -214 (Repl. 2018).

At the Section Nine hearing on July 14, Dr. Yalamanchili testified that he had

diagnosed Le, in his current state, with schizoaffective disorder. He said Le had been given

the first dose of Invega that day to treat the disorder. The State introduced two exhibits

through Dr. Yalamanchili: exhibit 1, titled “Master Treatment Plan”; and exhibit 2, titled

“Progress Notes.” The Master Treatment Plan contains a diagnosis of “acute psychosis,” and

the Progress Notes provide an “assessment” of “schizoaffective disorder, bipolar type.” Dr.

Yalamanchili testified that acute psychosis described Le’s symptoms at Le’s initial

presentation and that his ultimate diagnosis after continued evaluation was schizoaffective

disorder. On July 17, the circuit court entered an order for Le’s involuntary admission for a

3 period not to exceed forty-five days (“Section Nine Order”). Le appeals the Section Nine

Order.1

Le contends that the circuit court’s Section Nine Order is invalid “due to procedural

violations of statutory mandates,” specifically alleging three violations. The statutory scheme

for evaluating and treating a person who is dangerous to himself or others is set forth in

Arkansas Code Annotated sections 20-47-201 to -230 (Repl. 2018 & Supp. 2023), titled

“Commitment and Treatment.” The first violation alleged by Le is that he was given Invega,

a long-acting medication, before the Section Nine hearing in violation of section 20-47-

218(b)(2)(A). This provision sets forth the following limitations on treatment during

detention: “During the initial period of evaluation and treatment, psychotherapy and oral

or intermuscular medication may be used if the effects of the medication on the behavior of

the individual do not exceed seventy-two (72) hours.” Ark. Code Ann. § 20-47-218(b)(2)(A).

The parties do not dispute that “initial period of evaluation and treatment” is not

specifically defined in the statutory scheme, and the testimony is clear that Invega is a long-

acting medication that was provided to Le before the Section Nine hearing. Le argued that

“initial period of evaluation and treatment” included the entire period before the Section

Nine hearing. The circuit court disagreed, determining that the “initial period of evaluation

and treatment” referred to the seventy-two hours between detainment and the probable-

1 The forty-five days for treatment that was ordered by the circuit court has clearly expired. Nevertheless, we reach the merits of Le’s appeal because cases like this will always become moot before litigation can run its course. See Chatman v. State, 336 Ark. 323, 985 S.W.2d 718 (1999); Campbell v. State, 311 Ark. 641, 846 S.W.2d 639 (1993).

4 cause hearing. In other words, the court found that long-acting medication could be provided

after the Section Five hearing but before the Section Nine hearing.

We review issues of statutory interpretation de novo and are not bound by the circuit

court’s interpretation of a statute. Bell v. McDonald, 2014 Ark. 75, at 4, 432 S.W.3d 18, 21.

However, in the absence of a showing that the circuit court erred, its interpretation will be

accepted as correct on appeal. Id., 432 S.W.3d at 21. The first rule in considering the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
2025 Ark. App. 165, 709 S.W.3d 833, Counsel Stack Legal Research, https://law.counselstack.com/opinion/chuong-le-v-state-of-arkansas-arkctapp-2025.